Nrg-Gy022- Assessment Of Carboplatin Clearance Predictors: A Pk Study On Nci-Sponsored Clinical Trials Or Standard Of Care Treatments Using Carboplatin
Posted Date: Feb 27, 2020
- Investigator: Trisha Wise-Draper
- Specialties: Cancer, Oncology
- Type of Study: Observational/Survey
The main goals of this study are to 1. Evaluate the success of targeting a carboplatin AUC with our current approach to dosing carboplatin. 2. Assess the performance of CG, MDRD-4, and CKPD-EPI based on IDMS calibrated serum creatinine in predicting mGFR in patients with cancer and 3. Define the relationship of mGFR and carboplatin clearance in patients with cancer.
Criteria:
To Be Eligible: Must Receive Treatment With Intravenous Carboplatin As Part Of Trial Or Soc, Age 18+, No Recent Hx Of Kidney Injury Or Sickle Cell, No Significant Edema Or Ascites, No Amputees
Keywords:
Carboplatin, Phase 1
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com